TNF and metabolic dysfunction-associated steatotic liver disease: The results of previous studies showed that treating the mice with anti‐TNF antibodies improved NAFLD, indicating that the drugs, which can prevent inflammatory response, may be beneficial for NAFLD (Li et al., 2003).